Form 4: Tectonic Therapeutic Director Timothy Springer Acquires Additional Shares in Private Placement

Director Timothy Springer reports acquisition of Tectonic Therapeutic shares through a private placement and holdings via an LLC.

Summary

• Timothy Springer, a director and 10% owner of Tectonic Therapeutic, Inc., reported changes in beneficial ownership.
• On February 5, 2025, Springer acquired 129,294 shares of common stock at $54.14 per share and 660,000 shares at $50 per share through a private placement.
• Following these transactions, Springer directly owns 4,226,058 shares and indirectly owns 970,223 shares through TAS Partners LLC and 186,134 shares through his spouse.
• The private placement was previously announced on February 3, 2025, in the Issuer's Current Report on Form 8-K.
• Springer disclaims beneficial ownership of shares held by TAS Partners LLC except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of share acquisition by a director. The director's investment could be seen as a positive signal, but it's not overwhelmingly positive.

Positives

• A director's increased investment in the company may signal confidence in its future prospects.

Management Comments

• The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The increased stake of a director could be viewed positively by shareholders.

Key Dates